Isolation and identification of 23,25-dihydroxyvitamin D3, an in vivo metabolite of vitamin D3.
Vitamin D supplemented rats produce a metabolite of 25-hydroxy[3 alpha-3H]vitamin D3 that is easily separated from known metabolites by using high-performance liquid chromatography. The production of this metabolite in vivo as well as 1,25-dihydroxyvitamin D3, 24(R),25-dihydroxyvitamin D3, and 25-hydroxyvitamin D3 26,23-lactone is largely if not totally eliminated by nephrectomy. Kidney homogenates from vitamin D supplemented chickens incubated with 25-hydroxyvitamin D3 produce significant quantities of the new, unknown metabolite. This metabolite was isolated in pure form from such incubation mixtures by using both straight-phase and reversed-phase high-performance liquid chromatography. This metabolite has been positively identified as 23,25-dihydroxyvitamin D3 by ultraviolet absorption spectrophotometry, mass spectrometry, and derivatization. This structure was confirmed by chemical synthesis of both C-23 stereoisomers. Although the natural product exactly comigrates with one of the synthetic isomers, the exact stereochemistry of the natural product remains unknown. It is possible that this new metabolite is an intermediate in the biosynthesis of 25-hydroxyvitamin D3 26,23-lactone.
D000818:Animals; D002112:Calcifediol / Q000031:analogs & derivatives*; D002645:Chickens; D002762:Cholecalciferol / Q000378:metabolism*; D002851:Chromatography, High Pressure Liquid; D004100:Dihydroxycholecalciferols / Q000302:isolation & purification*; D006887:Hydroxycholecalciferols / Q000302:isolation & purification* / Q000378:metabolism; D013058:Mass Spectrometry; D009392:Nephrectomy; D051381:Rats; D013056:Spectrophotometry, Ultraviolet; D013237:Stereoisomerism
D004100:Dihydroxycholecalciferols; D006887:Hydroxycholecalciferols; D002762:Cholecalciferol; C026396:calcifediol lactone; C031699:23,25-dihydroxyvitamin D3; D002112:Calcifediol